Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 1115 results for "s e l"

FBR Capital Initiates LendingClub Corporation (NYSE:LC) Stock Coverage With a Outperform Rating and Target Price of $16.00
Octafinance

FBR Capital Initiates LendingClub Corporation (NYSE:LC) Stock ...

LendingClub Corporation (NYSE:LC) Price Target & New Coverage by FBR Capital Equity research analysts at FBR Capital has initiated coverage on LendingClub Corporation (NYSE:LC) with Outperform rating. The TP for LC is $16.00. It indicates a ... Octafinance, 26 minutes ago

3,472 images for s e l

DAPs Magic, 2 days ago
MovieWeb, 2 days ago
TheDay.com, 1 hour ago
DubaiNight, 10 hours ago
Newsarama, 21 hours ago
Newsarama, 21 hours ago
Newsarama, 21 hours ago
Newsarama, 21 hours ago
Newsarama, 21 hours ago
The Guardian Express, 3 days ago
Octafinance

Kindred Healthcare Inc (NYSE:KND) Had Its Price Target Decreased by 10.64% at UBS Securities to $21.00

Kindred Healthcare Inc (NYSE:KND) Target Change In a research report revealed to clients by UBS Securities on Monday morning, Kindred Healthcare Inc (NYSE:KND) had its target lowered to $21.00. The firm right now has Neutral rating on the stock. ...
 Octafinance26 minutes ago Canaccord Genuity Analyst Reaffirmed $85.00 Price Target on WellCare Health Plans (NYSE:WCG) stock, While Reiterating Hold Rating  Octafinance2 hours ago Wellcare Health Plans Inc (NYSE:WCG) Had Its PT Raised by Analysts at Canaccord Genuity to $85.00  Octafinance4 hours ago
Octafinance

JP Morgan Initiates Coverage on Karyopharm Therapeutics Inc (NASDAQ:KPTI) with Overweight and with $20.00 Target

Karyopharm Therapeutics Inc (NASDAQ:KPTI) Price Target & New Coverage by JP Morgan JP Morgan issued Overweight rating on Karyopharm Therapeutics Inc (NASDAQ:KPTI). The firm began coverage on shares of KPTI in an analyst report released on Monday, ...
 Octafinance2 hours ago Karyopharm Therapeutics (NASDAQ:KPTI) is Now Covered by Analysts at JP Morgan. They Set a Overweight Rating on the Stock  Octafinance2 hours ago Morgan Stanley Has Initiated Coty (NYSE:COTY) Coverage With Equal Weight Rating and $31.00 Target  Octafinance1 day ago Morgan Stanley Begins Coverage on Procter & Gamble Co (PG)  American Banking News1 day ago
Octafinance

Jones Lang Lasalle Incorporated (NYSE:JLL) Had Its TP Upgraded by Researchers at Barclays Capital to $182.00

Jones Lang Lasalle Incorporated (NYSE:JLL) Target Raised In analysts report sent to clients and investors by Barclays Capital on Monday, 9 February, Jones Lang Lasalle Incorporated (NYSE:JLL) had its TP boosted to $182.00. The firm at present has ...
 Octafinance26 minutes ago Equity Analysts at Barclays Reconfirmed their Overweight rating for Jones Lang LaSalle Incorporated (NYSE:JLL). The Target Price per Share is $182.00  Octafinance2 hours ago
MobileSyrup.com

Hands-on with the new Moto 360: Choice matters

3:00pm [embedded content] Motorola hasn't rested on its laurels in the twelve months since it released the original Moto 360. Despite being at the top of the Android Wearable heap, the company has endeavoured to find new audiences for its ...
 MobileSyrup.com29 minutes ago
Washington Post

Family, friends, dignitaries pay respects to Mandel at Md. State House

By , Maryland's political establishment paid their respects Wednesday to former governor Marvin Mandel, who flag-draped coffin is scheduled to lie in state at the Annapolis State House until 8 p.m. The coffin arrived in a hearse at about 9:40 ...
 Washington Post37 minutes ago
Dentistry IQ

Arginine: New study exposes additional oral health benefits

This article originally appeared in RDH eVillage Focus, a newsletter prepared for dental professionals looking for hard-hitting, current information. You can subscribe here. When combined with calcium, arginine has been clinically proven to be ...
 Dentistry IQ38 minutes ago Soft drinks: Hard on the body  Dentistry IQ2 hours ago
Octafinance

H.C. Wainwright Initiates Coverage on Recro Pharma (NASDAQ:REPH) Stock With Buy Rating, $19.0 Target

Recro Pharma (NASDAQ:REPH) Price Target & New Coverage by H.C. Wainwright H.C. Wainwright issued Buy rating on Recro Pharma (NASDAQ:REPH). The firm started coverage on shares of REPH in a research note released on Monday morning. H.C. Wainwright's ...
 Octafinance3 hours ago Recro Pharma (NASDAQ:REPH) Stock: H.C. Wainwright Initiates Coverage with Buy Outlook  Octafinance3 hours ago Alexion Pharma (NASDAQ:ALXN) 29.29% Upside Potential Indicated by Raymond James's Target  Octafinance1 day ago H.C. Wainwright Has Started Coverage on NephroGenex (NASDAQ:NRX) with Buy and with $9 Target  Octafinance1 day ago
Reuters

Baltimore judge allows charges against officers in Freddie Gray case

Officer Caesar R. Goodson Jr., Officer Edward M. Nero, Officer Garrett E Miller (top L-R), Officer William G. Porter, Lt. Brian W. Rice, Sgt. Alicia D. White (bottom L-R), are pictured in these undated booking photos provided by the Baltimore Police ...
 Reuters3 hours ago
Octafinance

Third Point Reinsurance (NYSE:TPRE) Buy Rating Reaffirmed at Compass Point; The Price Target is Set to $16.0

Third Point Reinsurance (NYSE:TPRE) Rating Restated The broker have set target price per share of $16.0 on Third Point Reinsurance (NYSE:TPRE) shares. This is 18.17% from the last stock close price. In a research report revealed to clients and ...
 Octafinance2 hours ago Analysts Give $87.00 Consensus Price Target to PS Business Parks (NYSE:PSB)  WKRB News7 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less